January 15, 2020
The Ministry of Health, Labor and Welfare (MHLW) on January 14 approved two HIV drugs, MSD’s Pifeltro (doravirine) and ViiV Healthcare’s Dovato (dolutegravir + lamivudine), which are expected to soon join the NHI price list under a fast-track reimbursement scheme...read more